Related by context. All words. (Click for frequent words.) 76 severe hypercholesterolemia 72 Peginterferon alfa 2b 72 Evoltra ® 72 MAGE A3 ASCI 72 R sorafenib tablets 72 SPRYCEL ® 71 Pivotal Phase III 71 acetonide FA 71 Civacir 71 Initiate Clinical Trial 71 ATPace TM 71 FOLOTYN ® 70 refractory chronic lymphocytic 70 Zenvia ™ 70 balsalazide tablet 70 IL# PE#QQR 70 thetreatment 70 SYCREST 70 Begins Dosing 70 sNDAs 70 Aceon 70 oral methylnaltrexone 70 successfully commercialize Iluvien 69 G#DT 69 reslizumab 69 herpetic keratitis 69 Phenoptin 69 novel emulsion formulation 69 Angiox ® 69 Raptiva R 69 omacetaxine mepesuccinate 69 HeFH 69 ZOLINZA 69 CINTREDEKIN BESUDOTOX 69 Soliris eculizumab 69 catheter occlusion 69 Initiates Enrollment 69 Initiates Phase III 69 Aryplase 69 esophageal candidiasis 69 hyperphenylalaninemia HPA due 69 Completes Patient Enrollment 69 etanercept Enbrel 69 UPLYSO 69 docetaxel Taxotere ® 69 histamine dihydrochloride 69 Phase IIIb clinical 69 Neulasta R 69 HoFH 69 induced macular edema 69 Dacogen injection 69 Pruvel 69 oropharyngeal candidiasis OPC 69 phase III isavuconazole 69 Eliquis 69 Initiates Phase II 69 CINQUIL 69 Somatuline R Depot 69 Gamunex C 68 interferon gamma 1b 68 Targretin capsules 68 Tarceva TM 68 lintuzumab SGN 68 Soliris TM eculizumab 68 Actimmune ® 68 alemtuzumab MS 68 Submits Response 68 ELIQUIS 68 MOVIPREP R 68 Octreolin 68 Pegloticase 68 REBETOL combination therapy 68 Vitrasert R 68 Tykerb lapatinib 68 Panzem R 68 acyclovir Lauriad R 68 OvaRex ® MAb 68 REBETOL combination 68 exocrine pancreatic insufficiency EPI 68 PrevOnco 68 Personalized Immunotherapy 68 miconazole MBT 68 Meets Primary Endpoint 68 intravenous acetaminophen 68 ORENCIA R 68 oxymorphone ER 68 forodesine 68 Presents Preclinical 68 Kit CD# positive 68 Egrifta 68 myelodysplastic myeloproliferative diseases 68 Achieves Primary Endpoint 68 alvespimycin 68 evaluating satraplatin 68 Plicera 68 Kuvan R 68 panitumumab Vectibix 68 Vidaza R 68 BENLYSTA ® 68 rheumatoid arthritis psoriatic arthritis 67 Velac 67 Heterozygous Familial Hypercholesterolemia 67 relapsed MM 67 miconazole Lauriad 67 CONBRIZA 67 PI3K/Akt pathway inhibitor 67 Xcytrin R 67 BrachySil TM 67 delivers fluocinolone acetonide FA 67 Trobalt 67 including eniluracil ADH 67 Firazyr 67 Forodesine HCl 67 phase IIb III 67 sorafenib tablets 67 Sanctura XR 67 ospemifene 67 proprietary intravenous formulation 67 Romidepsin 67 Esbriet ® 67 Prodarsan R 67 Orphan Status 67 ORENCIA ® 67 Dementia Related Psychosis 67 Oracea TM 67 TELINTRA 67 injectable formulations 67 Icatibant 67 DIFICID ™ 67 LymphoStat B TM 67 Levoleucovorin 67 Vidaza ® 67 Junovan 67 corticotropin injection 67 TBC# 67 THALOMID 67 Files IND 67 chronic immune thrombocytopenic 67 Aviptadil 67 sublingual tablets 67 ALGRX 67 fusion enhancers 67 Patients Treated With 67 RANK Ligand inhibitor 67 INSPIRE Trial Phase III 67 Irinotecan Hydrochloride Injection 67 MKC# 67 QNEXA 67 ALN HPN 67 Reports Preclinical Data 67 SUTENT ® 67 Vidaza azacitidine 67 MKC# MT 67 hypereosinophilic syndrome 67 Noxafil 67 Receives Positive Opinion 67 lumiliximab 67 Eloxatin ® 67 reduce serum phosphate 67 Biologic License Application BLA 67 sevelamer carbonate 67 PDX pralatrexate 67 ARIKACE ™ 67 intranasal formulation 67 pediatric pontine glioma 67 Hedgehog Pathway Inhibitor 67 MGd 67 ALN PCS 67 metaglidasen 67 oral picoplatin 67 QNEXA ® 67 hereditary deficiency 67 STELARA TM 67 selective modulator 67 2 methoxyestradiol 67 Navelbine R 67 invasive candidiasis 67 SANVAR 67 Muraglitazar 67 HCl capsules 67 Vectibix panitumumab 67 TYGACIL 67 R lenalidomide 67 oral salmon calcitonin 66 Arranon 66 phase IIb trial 66 Proellex TM 66 Nexavar sorafenib 66 Phase 2b Clinical Trial 66 Danazol 66 retinal vein occlusion induced 66 www.soliris.net 66 RNAi therapeutic targeting PCSK9 66 oral prodrug 66 Triapine R 66 Initiates Phase 2b 66 Receives Orphan Drug Designation 66 OMNARIS HFA 66 Cimzia TM 66 oral deforolimus 66 chronic HBV 66 TRISENOX ® 66 sevelamer hydrochloride 66 SIMPONI ® 66 Fast Track designations 66 virus HCV protease inhibitor 66 EVIZON TM squalamine lactate 66 CYT# potent vascular disrupting 66 orally administered inhibitor 66 RoACTEMRA 66 cisplatin gemcitabine 66 acitretin 66 oxypurinol 66 acyclovir Lauriad ® 66 rhIGF-I/rhIGFBP-3 66 thalidomide Thalomid 66 LEP ETU 66 exocrine pancreatic insufficiency 66 Alvesco R 66 Sebivo 66 IONSYS TM 66 refractory APL 66 Initiates Clinical Trial 66 Ophena TM 66 adecatumumab MT# 66 volociximab 66 toenail onychomycosis 66 prokinetic agent 66 Amoxicillin PULSYS Phase III 66 POSIDUR TM 66 Increlex R 66 Proquin XR 66 NeuroSTAT ® 66 Mepact 66 Genz # 66 efaproxiral 66 TRISENOX 66 YONDELIS 66 Panzem R NCD 66 Trofex 66 Onrigin 66 Thalomid ® 66 trastuzumab DM1 T DM1 66 sapropterin dihydrochloride Tablets 66 Zemplar Capsules 66 Cimzia ® certolizumab pegol 66 IV Busulfex 66 sitaxsentan 66 Zemiva TM 66 vidofludimus 66 ELACYT 66 Romiplostim 66 Zorbtive TM 66 diarrhea predominant irritable 66 HP Acthar Gel repository 66 Initiates Clinical 66 riociguat 66 pancreatic insufficiency 66 Diamyd r 66 treat chronic sinusitis 66 Rebif ® 66 Pyridorin 66 BRILINTA 66 Anturol TM 66 ARCOXIA 66 Cellegesic 66 relapsed ALL 66 potentially hepatotoxic 66 Evoltra 66 sunitinib Sutent 66 Gleevec Glivec 66 Dalbavancin 66 PrevOnco ™ 66 novel oral anticoagulant 66 TYZEKA 66 LibiGel ® 66 TASKi3 66 MAA submission 66 XL# anticancer compounds 66 pediatric Crohn disease 66 Somatuline R Autogel R 66 Troxatyl 66 Marketing Authorisation Application MAA 66 BLA filing 66 novel VDA molecule 66 metastatic colorectal carcinoma 66 Velcade bortezomib 66 LEVADEX ™ 66 Spiegelmer ® 66 Glatiramer Acetate 66 Cloretazine ® 66 adenosine injection 66 REMINYL ® 66 mecasermin 66 PLAVIX ® 66 lomitapide 66 buccal spray 66 Solazed 66 Modrenal R 66 IV APAP 66 PGL# 66 Kuvan TM sapropterin 66 Saforis 66 Known hypersensitivity 66 dyslipidemia hypertension diabetes 66 Presents Positive 66 HYVISC R 66 human C1 inhibitor 66 dextromethorphan quinidine 66 Junovan TM 66 MAXY VII 66 sodium thiosulfate STS 66 hyaluronidase enzyme 66 pain palliation 66 tolevamer 66 Zavesca R 66 RAPTIVA 66 T Pred 66 Dual Opioid 66 Dyloject TM 66 5 lipoxygenase inhibitor 66 Cancidas 66 Losartan 66 Cloretazine 66 ABILIFY ® 66 OHR/AVR# 66 Huntexil 66 ularitide 66 Synvisc ONE 65 familial hypercholesterolemia FH 65 Fondaparinux 65 oral ridaforolimus 65 methylnaltrexone bromide 65 OvaRex R 65 non splenectomized 65 Androxal TM 65 rufinamide 65 Raptiva ® 65 ISTODAX 65 SNT MC# 65 midstage clinical 65 Xelox 65 neratinib 65 NB S# strontium malonate 65 kidney urologic 65 Pivotal Phase 65 investigational monoclonal antibody 65 Entereg R 65 generation purine nucleoside 65 Rhucin ® recombinant 65 PEG SN# 65 Sanvar R 65 galiximab 65 Levetiracetam 65 Premarket Approval Application 65 CIMZIA TM certolizumab pegol 65 evaluating tivozanib 65 miconazole Lauriad ® 65 Campath alemtuzumab 65 R Saizen R 65 Linagliptin 65 Phase III ADT 65 Pemetrexed 65 parecoxib 65 multicenter Phase III 65 aripiprazole Abilify 65 Receives Approvable Letter 65 Gemzar gemcitabine 65 SUPPRELIN R LA 65 Plenaxis TM 65 Demonstrates Sustained 65 ribavirin USP 65 FOSAMAX PLUS D 65 corticosteroid dexamethasone 65 ACEON R perindopril erbumine 65 Combination REOLYSIN R 65 Friedreich Ataxia FRDA 65 naïve HCV 65 Begins Clinical Trial 65 orally inhaled migraine 65 Liprotamase 65 vapreotide acetate 65 ALN VSP Phase 65 TEMODAL 65 XP# XP# 65 ruxolitinib 65 GTC recombinant human 65 antiplatelet medications 65 Investigational Treatment 65 LEUKINE 65 SILENOR 65 Submits Supplemental 65 PEGINTRON TM 65 OLEPTRO 65 lymphoid malignancies 65 AzaSite Plus 65 atherothrombotic events 65 R abatacept 65 Temodar ® 65 nasal calcitonin product 65 Pafuramidine 65 lexidronam injection 65 pregabalin Lyrica 65 anti angiogenic agents 65 rasagiline tablets 65 Vernakalant 65 COLAZAL R 65 Brinavess 65 GATTEX ™ 65 Silodosin 65 SIMPONI TM 65 Darinaparsin 65 elotuzumab 65 rALLy 65 Certican 65 null responder 65 AMITIZA R 65 Advanced Melanoma 65 Increlex ® 65 Xeloda ® 65 relapsing remitting MS RRMS 65 adult chronic ITP 65 PRN FDA Approves 65 Zavesca r 65 candidate TNFerade biologic 65 Cypher Sirolimus 65 Zenpep 65 Hsp# Inhibitor 65 OMNARIS Nasal Spray 65 opioid induced bowel dysfunction 65 Nipent R 65 Corlux 65 ARIXTRA R 65 #I TM# 65 registrational 65 Fibrillex TM 65 Sudhir Agrawal D.Phil 65 AGHD 65 oxaliplatin injection 65 HepeX B 65 Demonstrates Positive 65 RSR# 65 BCR ABL inhibitor 65 Ranexa R 65 Shigamabs ® 65 inhaled AAT 65 diabetic neuropathic pain 65 Bristol Myers Squibb Pravachol 65 JAK2 Inhibitor 65 omega interferon 65 Submits Biologics License Application 65 secondary hyperparathyroidism 65 desvenlafaxine 65 levocetirizine 65 Marketing Authorization Applications 65 DPP4 inhibitor 65 HDL Selective Delipidation 65 TLK# 65 Kepivance 65 MyVax R 65 briakinumab 65 Cloretazine R 65 AMEVIVE 65 Submits IND 65 pegaptanib 65 PEG PAL 65 Removab 65 paclitaxel Taxol ® 65 Mg Uk 65 CLARITY study 65 Fludara ® 65 subcutaneous formulation 65 SEBIVO 65 Pivotal Trial 65 Diabetic Macular Edema 65 Ixempra 65 candidemia 65 ® bortezomib 65 Luveris 65 Soriatane 65 tramiprosate Alzhemed TM 65 Evoltra TM 65 biliary tract cancer 65 Keppra XR 65 PROVENGE ® 65 novel histone deacetylase 65 Somatuline Depot 65 Potelligent Technology 65 Metformin HCl 65 Mipomersen 65 mycophenolic acid 65 forodesine hydrochloride 65 Nexavar ® 65 recurrent glioblastoma multiforme 65 HuLuc# 65 Aplenzin 65 Onalta ™ 65 Bayer Onyx 65 cinacalcet HCl 65 Elagolix 65 Severe Sepsis 65 FRDA 65 Zirgan 65 Femara letrozole 65 adalimumab Humira 65 docetaxel Taxotere R 65 L BLP# 65 Telatinib 65 Myocet 65 DEB# 65 either acutely decompensated 65 HepeX B TM 65 TORISEL 65 recurrent herpes labialis 65 valtorcitabine 65 induce orthostatic hypotension 65 oropharyngeal candidiasis 65 recurrent malignant glioma 65 amrubicin 65 MYLOTARG 65 DCCR 65 treatment naive genotype 65 hereditary antithrombin deficiency 65 colesevelam HCl 65 homozygous familial hypercholesterolemia 65 PROVENGE sipuleucel T 65 FOLFOX6 chemotherapy regimen 65 sargramostim 65 Pivotal Study 65 evaluating mipomersen 65 small molecule tyrosine 65 ™ pralatrexate injection 65 PANVAC VF 65 LAF# 65 UCB Keppra 64 KRYSTEXXA TM pegloticase 64 Submits Investigational 64 Phase III Clinical Trial 64 Clolar ® 64 SinuNase TM 64 non constipating irritable 64 oxaliplatin Eloxatin 64 SomatoKine 64 lucinactant 64 demonstrated antitumor activity 64 Zelnorm Zelmac 64 post herpetic neuralgia PHN 64 Leukine ® 64 paroxetine sertraline 64 p# MAP kinase inhibitor 64 Cinquil 64 Solazed TM 64 investigational atypical antipsychotic 64 molecular imaging radiopharmaceutical 64 Temsirolimus 64 refractory metastatic colorectal cancer 64 Stimuvax R 64 Gonal f R 64 systemic juvenile idiopathic 64 Cleviprex TM clevidipine 64 primary hypercholesterolemia 64 orally disintegrating 64 ACOMPLIA R 64 de novo kidney transplant 64 pioglitazone hydrochloride 64 ceftazidime 64 candidate deforolimus 64 Phase Ib IIa 64 mild hepatic impairment 64 Vascular Wrap TM 64 Azedra 64 Crofelemer budesonide foam 64 VIAject R 64 TRIOLEX HE# APOPTONE HE# 64 PEGylated interferon beta 1a 64 Increlex TM 64 oral rivaroxaban 64 ® decitabine 64 Iluvien ® 64 Golimumab 64 humanized therapeutic 64 Gliadel Wafer 64 Files Investigational 64 Bazedoxifene 64 faropenem medoxomil 64 alvimopan 64 orphan designation 64 CRMD# 64 metastatic malignant 64 Annamycin 64 VEGF inhibitors 64 6R BH4 64 Serdolect ® 64 Sycrest 64 Viramidine 64 MyVax ® 64 Risperidone Oral Solution 64 arsenic trioxide injection 64 haematologic 64 UCB Cimzia 64 Zerenex TM 64 vinorelbine tartrate 64 Initiate Phase 64 Phase IIIb study 64 dalbavancin 64 dihydrochloride Tablets 64 Troxatyl TM 64 PDE# inhibitors 64 Tekamlo 64 SmPC 64 PHX# 64 IMiDs ® compound 64 granulated mesalamine 64 hypoxia activated prodrug 64 AFREZZA TM 64 antiangiogenic agents 64 Contrave# 64 ritonavir boosted danoprevir 64 Emtriva Viread 64 MK #B 64 Safinamide 64 multicenter Phase II 64 sitaxsentan sodium 64 myocardial infarction ventricular fibrillation 64 R vitespen 64 Uvidem 64 Cinryze ™ 64 edifoligide E2F Decoy 64 Evoltra R 64 unresectable recurrent 64 MACUGEN 64 Announces Tentative Approval 64 coronary stent merged 64 Dacogen decitabine 64 RhuDex ® 64 initiate Phase 1b 64 cutaneous T 64 Helicobacter pylori eradication 64 ITAX 64 Linjeta TM 64 vernakalant hydrochloride 64 SPRIX ® 64 Nexavar tablets 64 Novartis Reclast 64 eosinophilic asthma 64 adjuvant GIST 64 treats paroxysmal nocturnal 64 Entereg TM 64 torezolid phosphate 64 Rasilez HCT 64 Launches Generic Version 64 deferiprone 64 deforolimus 64 BEMA Granisetron 64 Xyrem ® 64 Adenoscan R 64 Topical Interferon Alpha 2b 64 cystinosis patients 64 AAG geldanamycin analog 64 Rhucin R 64 metastatic sarcomas 64 torsemide ER 64 ticagrelor Brilinta 64 Triapine 64 ONGLYZA ™ 64 OMAPRO ™ 64 Dapagliflozin 64 AZILECT ® 64 EP #R 64 ONCASPAR 64 Specifid 64 serotonin norepinephrine reuptake inhibitor 64 antiarrhythmic drug 64 Fosphenytoin 64 Prestara 64 INTEGRILIN 64 neovascular diseases 64 E2F Decoy 64 intravenous methylnaltrexone 64 ALN TTR# 64 Navelbine ® 64 Panzem ® 64 FOR FURTHER INFORMATION ABOUT 64 Hormone Refractory Prostate Cancer 64 RELOVAIR ™ 64 ADP receptor antagonist 64 Preotact R 64 Torisel temsirolimus 64 somatostatin analogues 64 Abrupt discontinuation 64 oral antidiabetic medication 64 Refractory Hodgkin Lymphoma 64 Fabry Disease 64 GERD migraine headaches 64 Progenta TM 64 DCVax ® Brain 64 REMICADE infliximab 64 commercialize toremifene 64 chronic idiopathic thrombocytopenic purpura 64 BioGlue R 64 clevidipine 64 heterozygous FH 64 sunitinib malate 64 indiplon capsules 64 evaluating bafetinib 64 MetroGel 64 generic Copaxone 64 Marketing Authorisation Application 64 malignant ascites 64 Virulizin R 64 aplindore 64 Genentech Rituxan 64 sapropterin dihydrochloride 64 essential thrombocythemia ET 64 vaginally administered lidocaine 64 Atypical Hemolytic Uremic Syndrome 64 Lamictal ODT 64 Boniva ibandronate 64 HepaGam B 64 Keppra ® levetiracetam 64 subcutaneous methylnaltrexone 64 non metastatic osteosarcoma 64 Supplemental Biologics License Application 64 Amrubicin 64 Application MAA 64 VISICOL R 64 GVAX ® 64 sorafenib Nexavar 64 Onco TCS 64 homozygous FH 64 Kamada AAT 64 overactive bladder syndrome 64 Adenuric R 64 include Phenoptin TM 64 Zelapar 64 FDA Accepts 64 Demonstrates Significant 64 Matrix Phase 2b 64 aerosolized surfactant 64 inflammatory autoimmune diseases 64 Phase IIb clinical trials 64 Combidex 64 Ceflatonin 64 terlipressin 64 antiangiogenic agent 64 Insegia 64 Prolongs Survival 64 FavId 64 paclitaxel poliglumex 64 atypical hemolytic uremic syndrome 64 cladribine tablets 64 pancreatic enzyme replacement 64 ponatinib 64 vaginal candidiasis 64 Allovectin 7 r 64 R bendamustine hydrochloride 64 Phase IIb III 64 XYOTAX TM 64 monoclonal antibody conjugated 64 humanised monoclonal antibody 64 octreotide acetate 64 hypoparathyroidism 64 ATPace 64 nephropathic cystinosis 64 QuadraSphere 64 Reclast zoledronic acid 64 icatibant 64 HuMax TAC 64 Neo Bladder Augment 64 candidate XP# 64 Exherin TM 64 rThrombin 64 Gonal f 64 IgG1 monoclonal antibody 64 INS# [001] 64 dihydrochloride 64 metformin XR 64 benign prostatic hypertrophy BPH 64 Submits NDA 64 Ketotransdel 64 LymphoStat B belimumab 64 targeted radiotherapeutic 64 subependymal giant cell 64 histone deacetylase inhibitor 64 basal insulin analogue 64 JAK Inhibitor 64 TREANDA 64 Oral Calcitonin 64 EVIZON ™ 63 IMA# 63 Gets FDA Clearance 63 Stage IIB 63 cysteamine bitartrate 63 investigational antiplatelet agent 63 THALOMID R 63 cannabinor 63 myopathy rhabdomyolysis 63 calcineurin inhibitor 63 PENTASA 63 pamidronate 63 Genasense R oblimersen 63 PROVIGIL 63 Vandetanib 63 Benign Prostatic Hyperplasia 63 Completes Enrollment 63 preclinical pharmacokinetic 63 FDA APPROVES 63 Adjuvant Treatment 63 refractory gout 63 Frova ® 63 Maribavir 63 liposomal formulation 63 initiated Phase Ib 63 ARCALYST ® 63 calcitonin salmon nasal spray 63 Oxybutynin 63 BARACLUDE R 63 PD LID 63 Captisol enabled 63 oritavancin semi 63 cilengitide 63 AGGRASTAT R tirofiban hydrochloride 63 markets HP Acthar 63 infusional 63 Vertex hepatitis C 63 BrachySil ™ 63 IMiDs ® 63 anidulafungin 63 AGGRASTAT ® tirofiban hydrochloride 63 beta 1a 63 sNDA filing 63 antiplatelet agent 63 bone marrow reticulin deposition 63 chronic thromboembolic pulmonary 63 IMPDH inhibitor 63 Efficacy Results 63 Emezine 63 indolent NHL 63 ILUVIEN ® 63 Vicriviroc 63 Medidur TM FA 63 Thrombin 63 Tibotec Therapeutics division 63 Mg Usa 63 novel trazodone formulation 63 Investigational Compound 63 tamoxifen citrate 63 systemic immunosuppressive drugs 63 Azacitidine 63 Fluconazole 63 ® lenalidomide 63 Product Monograph 63 IV acetaminophen 63 alpha interferons 63 CIMZIA R 63 ENTEREG ® 63 Zavesca ® 63 BRIM2 63 Calcitonin 63 Multiple Ascending Dose 63 Orencia abatacept 63 Exalgo TM 63 sulfonylurea metformin 63 Xenazine ® 63 Vimpat ® lacosamide 63 Complicated Skin 63 phase IIb clinical 63 AEGR 63 visilizumab 63 sNDA submission 63 pseudobulbar affect PBA 63 Qutenza TM 63 Campath ® 63 CIMZIA ® 63 oncolytic virus therapies 63 PROMUS Element Stent 63 treating neuropathic pain 63 BrachySil 63 HepaGam B TM 63 brivaracetam 63 capsule formulation 63 telaprevir VX 63 EvaMist TM 63 Generx ™ 63 dose escalation clinical 63 Femring ® 63 SAR# [004] 63 insulin glulisine 63 Teriparatide 63 AERx iDMS 63 tumor lysis syndrome 63 metformin accumulation 63 commercialize deforolimus 63 polycythemia vera essential thrombocythemia 63 squalamine 63 dirucotide MBP# 63 Starlix 63 VEGFR2 inhibitor 63 XAGRID 63 EVIZON TM 63 PNP inhibitor 63 receiving prophylactic anticoagulation 63 SinuNase ™ 63 receptor tyrosine kinase inhibitor 63 inhaled iloprost 63 weekly subcutaneous injections 63 beta estradiol 63 r hGH 63 DU #b 63 Phase #b/#a clinical 63 IBS C 63 ezogabine 63 DEEP AF 63 M# rationally 63 CINOD 63 rheumatoid arthritis inflammatory bowel 63 buccal tablets 63 Adjunctive Therapy 63 Glatiramer acetate 63 interferon alfa 2b 63 Fast Track Status 63 paclitaxel Taxol R 63 Presents Preclinical Data 63 deep venous thromboses 63 Pruvel ™ prulifloxacin 63 EOquin TM 63 pharmacogenomic translational research 63 RTP #i 63 desmopressin acetate 63 VIAject 63 bortezomib Velcade 63 Immunotherapeutic 63 Vascular Wrap 63 INTEGRILIN ® 63 Thelin tm 63 Altropane 63 Granted Orphan Drug 63 tezampanel NGX# 63 Mesafem 63 INCB# [001] 63 azilsartan medoxomil 63 EGS# 63 Anturol ® 63 Glucophage XR 63 octreotide implant 63 Calcium Acetate 63 TNF alpha antagonist 63 Chronic Idiopathic Constipation 63 zoledronic acid Reclast 63 injectable diclofenac 63 NPSP# 63 Eli Lilly Cymbalta 63 urocortin 2 63 Genasense ® oblimersen 63 Insulin detemir 63 oral beclomethasone dipropionate 63 HGS ETR2 63 SIR Spheres 63 Ophena 63 liver resection surgeries 63 Aflibercept 63 psoriasis Crohn disease 63 HCl Tablets 63 proprietary radiolabeled monoclonal 63 nalbuphine ER 63 GATTEX TM 63 metastatic hormone refractory 63 metastatic GIST 63 candidates Dyloject TM 63 INVEGA ® 63 bladder ovarian 63 MAb therapy 63 Perforomist ™ Inhalation Solution 63 ACAPODENE 63 AMPYRA ® 63 FDA Approvable Letter 63 tanespimycin 63 xanthine oxidase inhibitor 63 thorough QT 63 Opterone R 63 MERLIN TIMI 63 known teratogen substance 63 HuMax CD4 63 endothelin antagonist 63 developing Zerenex ferric 63 cUTI 63 everolimus tablets 63 Virulizin ® 63 pancreatic alpha 63 oral hypoglycemic agent 63 tafamidis 63 Iluvien TM 63 Phase Ib II 63 Daclizumab 63 apoptosis inducer 63 cMET 63 eritoran 63 Spiriva Handihaler 63 Behcet uveitis